Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor
Shirish M. Gadgeel, Shadan Ali, Philip A. Philip, Fakhara Ahmed, Antoinette Wozniak, Fazlul H. SarkarVolume:
110
Year:
2007
Language:
english
Pages:
10
DOI:
10.1002/cncr.23100
File:
PDF, 332 KB
english, 2007